Given that PGRN interacts with the same receptor as TNFα, many studies have shown that PGRN can inhibit TNFα‐mediated diseases such as osteoarthritis, intervertebral disc degeneration and colitis [49]. The gene discussed is TNF; the disease is osteoarthritis.